A Novel Pyroptosis-Related Gene Signature for Prediction of Disease-Free Survival in Papillary Thyroid Carcinoma
Open Access
- 29 December 2022
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (1) , 85
Abstract
Background: The incidence and recurrence rate of papillary thyroid carcinoma (PTC) are high. Thus, it is critical to accurately identify patients at high risk of recurrence. Pyroptosis is a type of programmed cell death closely related to the progression and prognosis of cancer. However, the role of pyroptosis in PTC remains unclear. Methods: Transcriptome data for PTC patients were obtained from The Cancer Genome Atlas database. The expression level of pyroptosis-related genes (PRGs) in PTC and normal tissues was identified. Based on these differentially expressed genes, a risk score model of disease-free survival (DFS) was established using least absolute shrinkage and selection operator Cox regression. In-cluster and quantitative real-time PCR validations were carried out. A nomogram, in combination with clinical factors, was also established. In addition, its relationship with immune characteristics and tumor gene mutations is discussed. Results: A risk score model with four PRGs, including CASP6, CASP9, IL-18, and NOD1, was established. The samples were divided into high- and low-risk clusters, according to the risk score, revealing significant differences in DFS between the two clusters. A nomogram was established combining age, lymph node metastasis and extrathyroidal extension. The area under the curve (AUC) of predicting one-, five-, and 10-year DFS in PTC patients was 0.745, 0.801, and 0.803, respectively. The low-risk cluster showed higher levels of immune infiltration and immune checkpoint gene expression, while the high-risk cluster demonstrated a higher tumor mutation burden. Conclusion: A predictive DFS model was established, based on PRGs, which may aid in identifying patients at high risk of recurrence. The present study helps to better understand the role of pyroptosis in the progression and prognosis of PTC.Keywords
Funding Information
- Applied Research Project of Commonweal Technology in Zhejiang Province (GF22H165705, 2022KY939, OO20190490, Z20210025)
- Zhejiang Medical and Health Science and Technology Plan Project (GF22H165705, 2022KY939, OO20190490, Z20210025)
- Project of Medical Scientific and Technology Program in Hangzhou (GF22H165705, 2022KY939, OO20190490, Z20210025)
This publication has 52 references indexed in Scilit:
- limma powers differential expression analyses for RNA-sequencing and microarray studiesNucleic Acids Research, 2015
- NOD1 and NOD2: Signaling, Host Defense, and Inflammatory DiseaseImmunity, 2014
- A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-upSurgery, 2013
- Estimating and comparing time‐dependent areas under receiver operating characteristic curves for censored event times with competing risksStatistics in Medicine, 2013
- Immuno-oncology: understanding the function and dysfunction of the immune system in cancerAnnals of Oncology, 2012
- Association between STAT1 activity and BRAF mutations in papillary thyroid carcinomasJournal of Surgical Oncology, 2012
- Caspase-6 and neurodegenerationTrends in Neurosciences, 2011
- Role of NF-κB in thyroid cancerMolecular and Cellular Endocrinology, 2010
- Interleukin-18Journal of Leukocyte Biology, 2003
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994